
United States · Research Services startup
20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug
Funding reportedLast round: Equity crowdfunding
Funding, as reported
20/20 Gene Systems filed 2 raises, $708K in all. Filings say how much was sold and to how many investors; they never name the investors.
Add your raise, your deck and your story, and put 20/20 Gene Systems in front of investors. Or tell us what we have wrong.